1st Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

PL 114-255, 21st Century Cures Act, implementation H.R. 4784, Lower Drug Costs Through Competition Act S. 974/H.R. 2212, CREATES Act of 2015 H.R. 2051, FAST Generics Drug safety issues Prescription drug abuse H.R. 1892/PL 115-123, Bipartisan Budget Act of 2018 H.R. 1625/PL 115-141, Consolidated Appropriations Act of 2018

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1625 (115th), H.R. 2212 (115th), H.R. 4784 (115th), H.R. 1892 (115th), S. 974 (115th), H.R. 2051 (115th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.